The Supreme Court decision in Merck Sharp & Dohme Corp v Clonmel Healthcare Ltd [2019] IESC 65 is an important judgment which takes a fresh look at the circumstances in which the Irish Courts should grant an interlocutory injunction. It has a particular resonance in the field of patents and Supplementary Protection Certificates (“SPCs”), where a series of recent judgments, including the judgment under appeal had taken a quite restrictive approach (see our briefing note on those earlier judgments here).
Are you looking for someone or
something in particular?
Share this post
Select how you would like to share using the options below